Literature DB >> 2859196

Neonatal thyrotoxicosis treated with exchange transfusion and Lugol's iodine.

J M Wit, L J Gerards, C Vermeulen-Meiners, H W Bruinse.   

Abstract

An infant with neonatal thyrotoxicosis was born to a mother who had become euthyroid after subtotal thyroidectomy for Graves' disease. Exchange transfusion resulted in a 50% decrease of serum thyroxine levels and thyroid stimulating immunoglobulins. After 10 days mild thyrotoxic signs reappeared with high serum thyroxine levels, which were treated successfully with Lugol's iodine for 4 weeks. TSI was undetectable at 7 weeks of age. TSI was present in breast milk.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2859196     DOI： 10.1007/bf00442312

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  9 in total

1.  Thyroid function during exchange transfusion.

Authors:  R D Milner; J G Ratcliffe
Journal:  Arch Dis Child       Date:  1975-01       Impact factor: 3.791

2.  Congenital graves disease. Four familial cases with long-term follow-up and perspective.

Authors:  D R Hollingsworth; C C Mabry
Journal:  Am J Dis Child       Date:  1976-02

3.  Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years.

Authors:  D Daneman; N J Howard
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

4.  Prenatal treatment of thyrotoxicosis to prevent intrauterine growth retardation.

Authors:  J H Check; I Rezvani; D Goodner; B Hopper
Journal:  Obstet Gynecol       Date:  1982-07       Impact factor: 7.661

5.  A receptor assay for the measurement of TSH receptor antibodies in unextracted serum.

Authors:  K Southgate; F Creagh; M Teece; C Kingswood; B Rees Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1984-05       Impact factor: 3.478

6.  Bioassay of thyroid-stimulating immunoglobulins using human thyroid cell cultures: optimization and clinical assessment.

Authors:  S P Bidey; N J Marshall; R P Ekins
Journal:  Clin Endocrinol (Oxf)       Date:  1983-08       Impact factor: 3.478

7.  Thyroid-stimulating immunoglobulins do not cause non-autonomous, autonomous, or toxic multinodular goitres.

Authors:  J H Bolk; J W Elte; J K Bussemaker; A Haak; D van der Heide
Journal:  Lancet       Date:  1979-07-14       Impact factor: 79.321

8.  Immunologic aspects of human colostrum and milk. I. Distribution characteristics and concentrations of immunoglobulins at different times after the onset of lactation.

Authors:  S S Ogra; P L Ogra
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406

9.  Thyroid function in healthy normal, low birthweight and preterm infants.

Authors:  J J Bongers-Schokking; W Schopman
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183
  9 in total
  3 in total

1.  Thyroid-stimulating immunoglobulins and thyroid function tests in two siblings with neonatal thyrotoxicosis.

Authors:  J M Wit; B Rees-Smith; F M Creagh; H W Bruinse; D van der Heide; R Docter; L J Gerards
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

Review 2.  Fetal neonatal hyperthyroidism: diagnostic and therapeutic approachment.

Authors:  Selim Kurtoğlu; Ahmet Özdemir
Journal:  Turk Pediatri Ars       Date:  2017-03-01

Review 3.  Neonatal thyroid disorders.

Authors:  A L Ogilvy-Stuart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.